DNA FY 2021 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$314M+309.4% YoY

Gross Profit

$184M58.7% margin

Operating Income

-$1.8B-582.6% margin

Net Income

-$1.8B-583.1% margin

EPS (Diluted)

$-55.53

Cash Flow

Operating Cash Flow

-$254M

Free Cash Flow

-$310M

Stock-Based Comp.

$1.6B

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$504M

Stockholders' Equity

$1.5B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$314M	$77M	+309.4%
Gross Profit	$184M	$61M	+201.7%
Operating Income	-$1.8B	-$137M	-1234.4%
Net Income	-$1.8B	-$127M	-1345.4%